Eli Lilly and Co. announced on Wednesday that prices for the company’s most commonly prescribed insulins will be reduced by up to 70 percent later this year, a move praised by President Joe Biden, who urged other drugmakers to follow. In a statement published on Mar. 1, the largest U.S. manufacturer of insulin said that […]
The U.S. Food and Drug Administration has approved the first systemic treatment for alopecia areata—commonly referred to as just alopecia—a disorder that causes hair to fall out often in clumps on the scalp, face, and sometimes on other areas of the body. The drug, Olumiant (baricitinib), made by Eli Lilly, is now approved to treat adults […]
The Food and Drug Administration (FDA) on Friday expanded its emergency use authorization (EUA) of Eli Lilly and Co’s dual-antibody therapy for mild to moderate COVID-19 to all children, including newborns. The treatment consists of bamlanivimab and etesevimab—two monoclonal antibodies that are administered by intravenous infusion. The two monoclonal antibodies are directed against the spike protein of SARS-CoV-2, […]
